Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan J Garber

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Archives of Internal Medicine|August 13, 2003
Benefits of combination therapy of insulin and oral hypoglycemic agentsAlan J Garber
The Lancet. Diabetes & Endocrinology|March 14, 2014
The importance of incretin therapies for managing type 2 diabetesAlan J Garber
Diabetes, Obesity & Metabolism|February 15, 2002
Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practiceAlan J Garber
Drugs|January 10, 2006
Premixed insulin analogues for the treatment of diabetes mellitusAlan J Garber
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 19, 2013
In responseAlan J Garber
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 31, 2018
IN RESPONSE TO AUTHORS' RESPONSE TO KARL Z. NADOLSKY, DO, RE: CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARYAlan J Garber,
Journal of Clinical Hypertension (Greenwich, Conn.)|April 7, 2011
Hypertension and lipid management in prediabetic statesAlan J Garber
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 27, 2015
ANTI-OBESITY PHARMACOTHERAPY AND THE POTENTIAL FOR PREVENTING PROGRESSION FROM PREDIABETES TO TYPE 2 DIABETESAlan J Garber
Clinical Cornerstone|June 13, 2003
Cardiovascular complications of diabetes: prevention and managementAlan J Garber
Diabetes Care|April 29, 2011
Incretin effects on β-cell function, replication, and mass: the human perspectiveAlan J Garber
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Archives of Internal Medicine|August 13, 2003
Benefits of combination therapy of insulin and oral hypoglycemic agentsAlan J Garber
The Lancet. Diabetes & Endocrinology|March 14, 2014
The importance of incretin therapies for managing type 2 diabetesAlan J Garber
Diabetes, Obesity & Metabolism|February 15, 2002
Attenuating CV risk factors in patients with diabetes: clinical evidence to clinical practiceAlan J Garber
Drugs|January 10, 2006
Premixed insulin analogues for the treatment of diabetes mellitusAlan J Garber
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|October 19, 2013
In responseAlan J Garber
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|May 31, 2018
IN RESPONSE TO AUTHORS' RESPONSE TO KARL Z. NADOLSKY, DO, RE: CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2018 EXECUTIVE SUMMARYAlan J Garber,
Journal of Clinical Hypertension (Greenwich, Conn.)|April 7, 2011
Hypertension and lipid management in prediabetic statesAlan J Garber
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 27, 2015
ANTI-OBESITY PHARMACOTHERAPY AND THE POTENTIAL FOR PREVENTING PROGRESSION FROM PREDIABETES TO TYPE 2 DIABETESAlan J Garber
Clinical Cornerstone|June 13, 2003
Cardiovascular complications of diabetes: prevention and managementAlan J Garber
Diabetes Care|April 29, 2011
Incretin effects on β-cell function, replication, and mass: the human perspectiveAlan J Garber
Pageof 10